FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:869-870 March 20, 1997 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Genetic testing for susceptibility to familial adenomatous polyposis has considerable importance for the relatives of patients with the disease, because a mutation in the adenomatous polyposis coli (APC) gene, if present, invariably causes colon cancer. In this issue of the Journal, Giardiello and colleagues report the results of a survey of how physicians use and interpret a test for APC mutations.¹ They found that few patients received genetic counseling or provided written consent before being tested. If physicians misuse other genetic tests to the same extent, these findings are important. However, the study itself raises questions about consent . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Watson, P, Narod, S A, Fodde, R, Wagner, A, Lynch, J F, Tinley, S T, Snyder, C L, Coronel, S A, Riley, B, Kinarsky, Y, Lynch, H T (2003). Carrier risk status changes resulting from mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast-ovarian cancer. J. Med. Genet. 40: 591-596 [Abstract] [Full Text]  
• Kozlowski, L. T., Vogler, G. P., Vandenbergh, D. J., Strasser, A. A., O'Connor, R. J., Yost, B. A. (2002). Using a Telephone Survey to Acquire Genetic and Behavioral Data Related to Cigarette Smoking in "Made-Anonymous" and "Registry" Samples. Am J Epidemiol 156: 68-77 [Abstract] [Full Text]  
• Doyal, L., Tobias, J S, Warnock, M., Power, L., Goodare, H. (1998). Ethical debate: Informed consent in medical research • Informed consent---a response to recent correspondence • Changing the BMJ's position on informed consent would be counterproductive • Informed consent---a publisher's duty • Trial subjects must be fully involved in design and approval of trials • Studies that do not have informed consent from participants should not be published. BMJ 316: 1000-1005 [Full Text]  
• Gill, M., Richards, T. (1998). Meeting the challenge of genetic advance. BMJ 316: 570-570 [Full Text]  
• Melton, L. J. (1997). The Threat to Medical-Records Research. NEJM 337: 1466-1470 [Full Text]  
• Ross, L. F., Veatch, R. M. (1997). Consent for Clinical Research. NEJM 337: 282-283 [Full Text]